| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.00029 | 1 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.00019 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.00017 | 1 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.00015 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -5e-05 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 2.3e-05 | 1 |